• Conference Proceeding

Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM

Citation

Qian, Y., Hauber, A. B., Gonzalez, J. M., Posner, J., Mohamed, A. F., Tombal, B., ... Arellano, J. (2014). Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM. In [32], p. Abstract 117. .

Abstract